More systematic reviews were registered in PROSPERO each year, but few records' status was up-to-date.

Meta-analysis Methodological research PROSPERO Registration Systematic review Transparency

Journal

Journal of clinical epidemiology
ISSN: 1878-5921
Titre abrégé: J Clin Epidemiol
Pays: United States
ID NLM: 8801383

Informations de publication

Date de publication:
01 2020
Historique:
received: 22 07 2019
revised: 26 09 2019
accepted: 30 09 2019
pubmed: 8 10 2019
medline: 7 8 2020
entrez: 8 10 2019
Statut: ppublish

Résumé

To determine the proportion of systematic reviews (SRs) registered in PROSPERO and explore differences between publication years, review focus, and country. Secondary objectives were (1) to compare the characteristics of registered and nonregistered SRs and (2) to assess the up-to-dateness of the PROSPERO records' status. In November 2018, we searched PubMed for SRs that were eligible for registration in PROSPERO. We included a random sample of n = 500 SRs. Data were analyzed descriptively. Overall, 76 (15.2%) of the included SRs had been registered in PROSPERO. This proportion has increased with each year, up to 31.6% (36/114) in 2018. It did not notably differ depending on the reviews' focus. SRs from the United States or China were generally registered less frequently and SRs from Australia or Canada more frequently. Registered and nonregistered SRs did not differ regarding the number of authors or the time from submission to publication or from search to submission and publication. We could analyze 75 PROSPERO records, of which 63 (84.0%) were not up-to-date. Most SRs (49/75; 65.3%) were still listed as "ongoing." More SRs were registered in PROSPERO each year, but only few records' status was up-to-date.

Identifiants

pubmed: 31589953
pii: S0895-4356(19)30650-X
doi: 10.1016/j.jclinepi.2019.09.026
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

60-67

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Tanja Rombey (T)

Faculty of Health, School of Medicine, Institute for Research in Operative Medicine, Witten/Herdecke University, Cologne, Germany. Electronic address: tanja.rombey@uni-wh.de.

Katharina Doni (K)

Faculty of Health, School of Medicine, Institute for Research in Operative Medicine, Witten/Herdecke University, Cologne, Germany.

Falk Hoffmann (F)

Department of Health Services Research, School of Medicine and Health Sciences, Carl von Ossietzky University Oldenburg, Oldenburg, Germany.

Dawid Pieper (D)

Faculty of Health, School of Medicine, Institute for Research in Operative Medicine, Witten/Herdecke University, Cologne, Germany.

Katharina Allers (K)

Department of Health Services Research, School of Medicine and Health Sciences, Carl von Ossietzky University Oldenburg, Oldenburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH